1. Home
  2. REI vs NNNN Comparison

REI vs NNNN Comparison

Compare REI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

REI

Ring Energy Inc.

HOLD

Current Price

$1.29

Market Cap

383.0M

Sector

Energy

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$6.05

Market Cap

340.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REI
NNNN
Founded
2004
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.0M
340.2M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
REI
NNNN
Price
$1.29
$6.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 3.4M
228.8K
Earning Date
05-05-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $307,178,072.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.17
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
N/A
★ N/A
52 Week Low
$0.83
$5.13
52 Week High
$2.00
$51.33

Technical Indicators

Market Signals
Indicator
REI
NNNN
Relative Strength Index (RSI) 37.44 40.72
Support Level $1.23 $5.13
Resistance Level $1.42 $12.10
Average True Range (ATR) 0.05 0.53
MACD -0.03 0.19
Stochastic Oscillator 8.33 57.69

Price Performance

Historical Comparison
REI
NNNN

About REI Ring Energy Inc.

Ring Energy Inc is an independent oil and natural gas exploration and production company based in the United States. It is engaged in oil and natural gas development, production, acquisition, and exploration activities, currently focused on the Permian Basin of Texas. The company's drilling operations target the oil and liquids-rich producing formations in the Northwest Shelf and the Central Basin Platform, in the Permian Basin in Texas.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: